PJP vs. HELX
Compare and contrast key facts about Invesco Dynamic Pharmaceuticals ETF (PJP) and Franklin Genomic Advancements ETF (HELX).
PJP and HELX are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PJP is a passively managed fund by Invesco that tracks the performance of the Dynamic Pharmaceuticals Intellidex Index. It was launched on Jun 23, 2005. HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.
Performance
PJP vs. HELX - Performance Comparison
Loading graphics...
PJP vs. HELX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 0.14% | 27.98% | 9.63% | -2.18% | -2.16% | 14.58% | 21.36% |
HELX Franklin Genomic Advancements ETF | -8.14% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
Returns By Period
In the year-to-date period, PJP achieves a 0.14% return, which is significantly higher than HELX's -8.14% return.
PJP
- 1D
- 0.58%
- 1M
- -3.83%
- YTD
- 0.14%
- 6M
- 10.47%
- 1Y
- 25.83%
- 3Y*
- 12.33%
- 5Y*
- 6.80%
- 10Y*
- 6.48%
HELX
- 1D
- 0.90%
- 1M
- -2.17%
- YTD
- -8.14%
- 6M
- 5.21%
- 1Y
- 26.31%
- 3Y*
- 3.29%
- 5Y*
- -5.21%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PJP vs. HELX - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is higher than HELX's 0.50% expense ratio.
Return for Risk
PJP vs. HELX — Risk / Return Rank
PJP
HELX
PJP vs. HELX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | HELX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.39 | 1.10 | +0.30 |
Sortino ratioReturn per unit of downside risk | 1.91 | 1.63 | +0.28 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.21 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.87 | 1.33 | +0.54 |
Martin ratioReturn relative to average drawdown | 5.68 | 4.32 | +1.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PJP | HELX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 1.10 | +0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.43 | -0.22 | +0.64 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.35 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.21 | +0.38 |
Correlation
The correlation between PJP and HELX is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
PJP vs. HELX - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 1.01%, more than HELX's 0.43% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 1.01% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
HELX Franklin Genomic Advancements ETF | 0.43% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PJP vs. HELX - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum HELX drawdown of -58.75%. Use the drawdown chart below to compare losses from any high point for PJP and HELX.
Loading graphics...
Drawdown Indicators
| PJP | HELX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | -58.75% | +21.69% |
Max Drawdown (1Y)Largest decline over 1 year | -11.68% | -18.01% | +6.33% |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | -58.75% | +41.24% |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | — | — |
Current DrawdownCurrent decline from peak | -5.28% | -42.36% | +37.08% |
Average DrawdownAverage peak-to-trough decline | -8.89% | -34.12% | +25.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.85% | 5.56% | -1.71% |
Volatility
PJP vs. HELX - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 6.41%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 8.75%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PJP | HELX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.41% | 8.75% | -2.34% |
Volatility (6M)Calculated over the trailing 6-month period | 11.50% | 15.40% | -3.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.92% | 24.21% | -5.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.97% | 24.26% | -8.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.42% | 27.46% | -9.04% |